Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Emerging molecular prognostic markers in human thyroid carcinoma.

De Antoni E.

G Chir. 2011 May;32(5):241-3. No abstract available.

PMID:
21619774
2.

Molecular markers in thyroid cancer diagnostics.

Kato MA, Fahey TJ 3rd.

Surg Clin North Am. 2009 Oct;89(5):1139-55. doi: 10.1016/j.suc.2009.06.012. Review.

PMID:
19836489
3.

Molecular pathology of thyroid tumors: diagnostic and prognostic relevance.

Sobrinho-Simões M, Eloy C, Vinagre J, Soares P.

Int J Surg Pathol. 2010 Jun;18(3 Suppl):209S-212S. doi: 10.1177/1066896910370886. Review. No abstract available.

PMID:
20484293
4.

Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma.

Corsello SM, Lovicu RM, Migneco MG, Rufini V, Summaria V.

Rays. 2000 Apr-Jun;25(2):257-66. Review. English, Italian.

PMID:
11370543
5.

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T.

Mod Pathol. 2008 Sep;21(9):1139-46. doi: 10.1038/modpathol.2008.105. Epub 2008 Jun 27.

6.

Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.

Kebebew E, Peng M, Reiff E, McMillan A.

Cancer. 2006 Jun 15;106(12):2592-7.

7.

Clinical implications of molecular markers in follicular cell-derived thyroid cancer.

Pinto AE, Leite V, Soares J.

Expert Rev Mol Diagn. 2009 Oct;9(7):679-94. doi: 10.1586/erm.09.54. Review.

PMID:
19817553
8.

New, clinically relevant molecular characterizations of thyroid cancer.

Davis PJ.

Curr Opin Endocrinol Diabetes Obes. 2009 Oct;16(5):359-60. doi: 10.1097/MED.0b013e3283307bd2. No abstract available.

PMID:
19654539
9.

[Biological markers in thyroid tumors].

Matsuo SE, Martins L, Leoni SG, Hajjar D, Ricarte-Filho JC, Ebina KN, Kimura ET.

Arq Bras Endocrinol Metabol. 2004 Feb;48(1):114-25. Epub 2004 Jun 1. Review. Portuguese.

10.

The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer.

Weber KB, Shroyer KR, Heinz DE, Nawaz S, Said MS, Haugen BR.

Am J Clin Pathol. 2004 Oct;122(4):524-31.

PMID:
15487449
11.

The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia.

Raphael SJ.

Endocr Pathol. 2002 Winter;13(4):301-11. Review.

PMID:
12665648
12.

[Clinical, morphologic and immunohistochemical factors of prognosis in papillary cancer of the thyroid].

Shkurko OA.

Vopr Onkol. 2008;54(1):19-24. Review. Russian. No abstract available.

PMID:
18416052
13.

Human telomerase reverse transcriptase (hTERT) gene expression in thyroid carcinoma: diagnostic and prognostic role.

Asaad NY, Abd El-Wahed MM, Mohammed AG.

J Egypt Natl Canc Inst. 2006 Mar;18(1):8-16.

14.

Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis.

Shi Y, Zou M, Farid NR.

Clin Endocrinol (Oxf). 1993 Sep;39(3):269-74.

PMID:
8222289
15.

[Immunohistochemistry of biomolecular markers of early thyroid cancer].

Paltsev MA, Kogan EA, Tuntsova OI.

Arkh Patol. 1997 Nov-Dec;59(6):18-23. Russian.

PMID:
9483213
16.

Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.

Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A.

Surgery. 2005 Dec;138(6):1102-9; discussion 1109-10.

PMID:
16360397
17.

Papillary thyroid carcinoma: an overview.

Al-Brahim N, Asa SL.

Arch Pathol Lab Med. 2006 Jul;130(7):1057-62. Review.

PMID:
16831036
18.

[Update on differenciated thyroid carcinoma].

Karayan L, Hadjadj S, Larsen CJ, Maréchaud R, Kraimps JL.

Bull Cancer. 2002 Jan;89(1):113-23. Review. French.

19.

Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?

Shibru D, Hwang J, Khanafshar E, Duh QY, Clark OH, Kebebew E.

Cancer. 2008 Sep 1;113(5):930-5. doi: 10.1002/cncr.23703.

20.

[Thyroid cancer: prognostic factors and treatment].

Ward LS, Assumpção LV.

Arq Bras Endocrinol Metabol. 2004 Feb;48(1):126-36. Epub 2004 Jun 1. Review. Portuguese.

Supplemental Content

Support Center